SpyGlass Pharma, Inc. (SGP) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2024: -$22.03M2025: -$32.70M-$32.70M
2024Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$32.70M-48.5%
2024-$22.03M